Insider filing · APGE
Jane Henderson
Director
profile →
Apogee Therapeutics, Inc.
APGE · Healthcare · 45 filings in 24 months
ticker →
Jane Henderson sold $609K of Apogee Therapeutics (APGE)
Executed Jan 2, disclosed Jan 6, 4 days later.
Value, as filed
$609K
8,000 sh across 3 lots
Executed
Jan 2
the trade date, as filed
Disclosed
Jan 6
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JHJane Henderson (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $609K of APGE (8,000 sh across 3 lots, as filed), executed Jan 2.
The name
APGEHealthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jane Henderson in APGE
APGESALE
Apogee Therapeutics, Inc.
$180K2,000 sh × $90.00
Exec Apr 16
Filed Apr 17 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $170K
2,000 sh × $85.00
Exec Mar 25
Filed Mar 27 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $120K
1,500 sh × $80.00
Exec Dec 19 2025
Filed Dec 23 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $112K
1,500 sh × $75.00
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $105K
1,500 sh × $70.00
Exec Nov 25 2025
Filed Nov 28 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $130K
2,000 sh × $65.00
Exec Nov 14 2025
Filed Nov 14 2025 · 5:30 PM ET